Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 586 AL 600

Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease

Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, Sperling R, Salloway S, Schofield PR, Masters CL, Martins RN, Rossor MN, Jucker M, Danek A, Förster S, Lane CA, Morris JC, Benzinger TL, Bateman RJ; Dominantly Inherited Alzheimer Network.

Neurology. 2015 Sep 1;85(9):790-8. doi: 10.1212/WNL.0000000000001903. Epub 2015 Aug 5.

Is dominantly inherited Alzheimer disease a clone of sporadic Alzheimer disease?

Knopman DS.

Neurology. 2015 Sep 1;85(9):750-1. doi: 10.1212/WNL.0000000000001897. Epub 2015 Aug 5.

What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?

Becker RE, Seeman MV, Greig NH, Lahiri DK.

Lancet Psychiatry. 2015 Aug;2(8):756-764. doi: 10.1016/S2215-0366(15)00214-X.

Current thinking on the mechanistic basis of Alzheimer's and implications for drug development

Ising C, Stanley M, Holtzman DM.

Clin Pharmacol Ther. 2015 Nov;98(5):469-71. doi: 10.1002/cpt.200. Epub 2015 Sep 10.

Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis

Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G, Barboni P, Pierelli F, Sadun AA, Parisi V.

PLoS One. 2015 Aug 7;10(8):e0134750. doi: 10.1371/journal.pone.0134750. eCollection 2015.

Technical Considerations in Brain Amyloid PET Imaging with 18F-Florbetapir

Trembath L, Newell M, Devous MD Sr.

J Nucl Med Technol. 2015 Sep;43(3):175-84. doi: 10.2967/jnmt.115.156679. Epub 2015 Aug 13.

Digital technologies for cognitive assessment to accelerate drug development in Alzheimer's disease

Leurent C, Ehlers MD.

Clin Pharmacol Ther. 2015 Nov;98(5):475-6. doi: 10.1002/cpt.212. Epub 2015 Sep 8.

Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances

Yin Y, Liu Y, Zhuang J, Pan X, Li P, Yang Y, Li YP, Zhao ZQ, Huang LQ, Zhao ZX.

Pharmacology. 2015;96(3-4):155-62. doi: 10.1159/000435889. Epub 2015 Aug 8.

Leptin in Alzheimer's disease

Magalhães CA, Carvalho MG, Sousa LP, Caramelli P, Gomes KB.

Clin Chim Acta. 2015 Oct 23;450:162-8. doi: 10.1016/j.cca.2015.08.009. Epub 2015 Aug 14.

Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed

Lacey L, Bobula J, Rüdell K, Alvir J, Leibman C.

Value Health. 2015 Jul;18(5):638-45. doi: 10.1016/j.jval.2015.03.1787. Epub 2015 Apr 10.

To Feed or Not to Feed? A Case Report and Ethical Analysis of Withholding Food and Drink in a Patient With Advanced Dementia

Meier CA, Ong TD.

J Pain Symptom Manage. 2015 Dec;50(6):887-90. doi: 10.1016/j.jpainsymman.2015.07.009. Epub 2015 Aug 20.

Understanding Conflicting Neuropathological Findings in Patients Clinically Diagnosed as Having Alzheimer Dementia

Salloway S, Sperling R.

JAMA Neurol. 2015 Oct;72(10):1106-8. doi: 10.1001/jamaneurol.2015.1804.

Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease

de Flores R, La Joie R, Chételat G.

Neuroscience. 2015 Nov 19;309:29-50. doi: 10.1016/j.neuroscience.2015.08.033. Epub 2015 Aug 22.

Alzheimer's Disease associated with Psychiatric Comorbidities

Garcez ML, Falchetti AC, Mina F, Budni J.

An Acad Bras Cienc. 2015 Aug;87(2 Suppl):1461-73. doi: 10.1590/0001-3765201520140716. Epub 2015 Aug 25.

Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease

Kuzmickienė J, Kaubrys G.

Med Sci Monit. 2015 Aug 31;21:2572-82. doi: 10.12659/MSM.895381.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias